These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26130118)

  • 1. Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
    Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D
    Circulation; 2015 Sep; 132(9):834-47. PubMed ID: 26130118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.
    Manaud G; Nossent EJ; Lambert M; Ghigna MR; Boët A; Vinhas MC; Ranchoux B; Dumas SJ; Courboulin A; Girerd B; Soubrier F; Bignard J; Claude O; Lecerf F; Hautefort A; Florio M; Sun B; Nadaud S; Verleden SE; Remy S; Anegon I; Bogaard HJ; Mercier O; Fadel E; Simonneau G; Vonk Noordegraaf A; Grünberg K; Humbert M; Montani D; Dorfmüller P; Antigny F; Perros F
    Am J Respir Cell Mol Biol; 2020 Jul; 63(1):118-131. PubMed ID: 32209028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
    Certain MC; Chaumais MC; Jaïs X; Savale L; Seferian A; Parent F; Georges M; Favrolt N; Bourdin A; Boissin C; Cottin V; Traclet J; Renard S; Noel V; Picard F; Girerd B; Ghigna MR; Perros F; Sitbon O; Bonniaud P; Humbert M; Montani D
    Chest; 2021 Mar; 159(3):1197-1207. PubMed ID: 32979348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple method to assess in vivo proliferation in lung vasculature with EdU: the case of MMC-induced PVOD in rat.
    Fabrice A; Benoît R; Valérie N; Lau E; Sébastien B; Frédéric P
    Anal Cell Pathol (Amst); 2015; 2015():326385. PubMed ID: 26345623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats.
    Zhang C; Lu W; Luo X; Liu S; Li Y; Zheng Q; Liu W; Wu X; Chen Y; Jiang Q; Zhang Z; Gu G; Chen J; Chen H; Liao J; Liu C; Hong C; Tang H; Sun D; Yang K; Wang J
    Br J Pharmacol; 2021 Jan; 178(1):217-235. PubMed ID: 33140842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalation of hydrogen gas protects against mitomycin-induced pulmonary veno-occlusive disease.
    Zhang C; Xing Y; Wu X; Jiang Q; Luo X; He W; Liu S; Lu W; Wang J
    Respir Res; 2024 Jul; 25(1):281. PubMed ID: 39014440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication].
    Montani D; Chaumais MC; Seferian A; Humbert M
    Bull Cancer; 2017 Feb; 104(2):202-204. PubMed ID: 27884394
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
    Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
    Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
    Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
    J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease.
    Chen Z; Zhang J; Wei D; Chen J; Yang J
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):677-689. PubMed ID: 33988041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin induced pulmonary veno-occlusive disease.
    Kunadu A; Stalls JS; Labuschagne H; Thayyil A; Falls R; Maddipati V
    Respir Med Case Rep; 2021; 34():101437. PubMed ID: 34401312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary veno-occlusive disease].
    Boucly A; Girerd B; Bourlier D; Nemlaghi S; Caliez J; Savale L; Jaïs X; Dorfmüller P; Simonneau G; Sitbon O; Humbert M; Montani D
    Rev Mal Respir; 2018 Feb; 35(2):160-170. PubMed ID: 29501213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model".
    Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D
    Circulation; 2016 Apr; 133(14):e592-3. PubMed ID: 27045136
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma.
    Gagnadoux F; Capron F; Lebeau B
    Lung Cancer; 2002 May; 36(2):213-5. PubMed ID: 11955658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter by Belge et al Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models".
    Belge C; Quarck R; Delcroix M
    Circulation; 2016 Apr; 133(14):e591. PubMed ID: 27045135
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
    Ranchoux B; Günther S; Quarck R; Chaumais MC; Dorfmüller P; Antigny F; Dumas SJ; Raymond N; Lau E; Savale L; Jaïs X; Sitbon O; Simonneau G; Stenmark K; Cohen-Kaminsky S; Humbert M; Montani D; Perros F
    Am J Pathol; 2015 Feb; 185(2):356-71. PubMed ID: 25497573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog.
    den Toom ML; Grinwis G; van Suylen RJ; Boroffka SA; de Jong P; van Steenbeek FG; Szatmári V
    Acta Vet Scand; 2018 Dec; 60(1):78. PubMed ID: 30518401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying age-associated exacerbation of pulmonary veno-occlusive disease.
    Prabhakar A; Wadhwa M; Kumar R; Ghatpande P; Gandjeva A; Tuder RM; Graham BB; Lagna G; Hata A
    JCI Insight; 2024 Sep; 9(19):. PubMed ID: 39269983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response.
    Prabhakar A; Kumar R; Wadhwa M; Ghatpande P; Zhang J; Zhao Z; Lizama CO; Kharbikar BN; Gräf S; Treacy CM; Morrell NW; Graham BB; Lagna G; Hata A
    Nat Cardiovasc Res; 2024 Jul; 3(7):799-818. PubMed ID: 39196173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
    Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
    Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.